Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Dongqing Yan, Anca Franzini, Anthony D. Pomicter, et al.
Blood Cancer Discovery (2021) Vol. 2, Iss. 3, pp. 266-287
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Mitochondrial sirtuins, metabolism, and aging
Zhejun Ji, Guang‐Hui Liu, Jing Qu
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 49, Iss. 4, pp. 287-298
Open Access | Times Cited: 136
Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis
Renqiang Sun, Zhiyong Zhang, Ruoxuan Bao, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 453-466
Closed Access | Times Cited: 87
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression
Tuo Hu, Surendra K. Shukla, Enza Vernucci, et al.
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1584-1600
Open Access | Times Cited: 87
Sirtuin Modulators: Past, Present, and Future Perspectives
Francesco Fiorentino, Nicola Mautone, Martina Menna, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 12, pp. 915-939
Open Access | Times Cited: 39
Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection
Emanuele Fabbrizi, Francesco Fiorentino, Vincenzo Carafa, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 852-852
Open Access | Times Cited: 35
Current Trends in Sirtuin Activator and Inhibitor Development
Karina Bursch, Christopher G. Goetz, Brian C. Smith
Molecules (2024) Vol. 29, Iss. 5, pp. 1185-1185
Open Access | Times Cited: 15
SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells
Mu‐Jie Lu, Jonathan Busquets, Valeria Impedovo, et al.
Cell Metabolism (2024) Vol. 36, Iss. 4, pp. 808-821.e6
Closed Access | Times Cited: 12
Mitochondrial Sirtuins in Cancer: A Revisited Review from Molecular Mechanisms to Therapeutic Strategies
Hui Shen, Wei Ma, Yue Hu, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2993-3013
Open Access | Times Cited: 9
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5
Francesco Fiorentino, Carola Castiello, Antonello Mai, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9580-9606
Open Access | Times Cited: 35
Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase**
Julie E. Bolding, Pablo Martín‐Gago, Nima Rajabi, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 47
Open Access | Times Cited: 34
The role of protein acetylation in carcinogenesis and targeted drug discovery
Jingru Yang, Cong Song, Xianquan Zhan
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Core-predominant gut fungus Kazachstania slooffiae promotes intestinal epithelial glycolysis via lysine desuccinylation in pigs
Jun Hu, Jianwei Chen, Qiliang Hou, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Mitochondrial sirtuins: Energy dynamics and cancer metabolism
Hojun Lee, Haejin Yoon
Molecules and Cells (2024) Vol. 47, Iss. 2, pp. 100029-100029
Open Access | Times Cited: 8
Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**
Nima Rajabi, Tobias Hansen, Alexander L. Nielsen, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 22
Open Access | Times Cited: 25
Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance
Katerina Miari, Mark Williams
British Journal of Pharmacology (2023) Vol. 181, Iss. 2, pp. 216-237
Open Access | Times Cited: 16
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity
Cristiana O’Brien, Tianyi Ling, Jacob M. Berman, et al.
Haematologica (2023)
Open Access | Times Cited: 15
Activation and inhibition of sirtuins: From bench to bedside
Francesco Fiorentino, Emanuele Fabbrizi, Antonello Mai, et al.
Medicinal Research Reviews (2024)
Open Access | Times Cited: 5
Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia
Vladimir Gašić, Teodora Karan-Djurašević, Djordje Pavlovic, et al.
Life (2022) Vol. 12, Iss. 11, pp. 1770-1770
Open Access | Times Cited: 20
New insights into the pathophysiology of methylmalonic acidemia
PamelaSara E. Head, Jordan L. Meier, Charles P. Venditti
Journal of Inherited Metabolic Disease (2023) Vol. 46, Iss. 3, pp. 436-449
Open Access | Times Cited: 11
The SIRT5-JIP4 interaction promotes osteoclastogenesis by modulating RANKL-induced signaling transduction
Ke-Cheng Zhu, Chunxiang Sheng, Linlin Zhang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia—A Promising Road Ahead
Piotr Strzałka, Kinga Krawiec, Aneta Wiśnik, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1009-1009
Open Access
Insights on the Modulation of SIRT5 Activity: A Challenging Balance
Matteo Mori, Giulia Cazzaniga, Fiorella Meneghetti, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4449-4449
Open Access | Times Cited: 16
Role of SIRT5 in cancer. Friend or Foe?
Francisco Alejandro Lagunas‐Rangel
Biochimie (2023) Vol. 209, pp. 131-141
Closed Access | Times Cited: 9
Bidirectional interplay between metabolism and epigenetics in hematopoietic stem cells and leukemia
Yu Wei Zhang, Katharina Schönberger, Nina Cabezas‐Wallscheid
The EMBO Journal (2023) Vol. 42, Iss. 24
Open Access | Times Cited: 9
Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia
Jamshid S. Khorashad, Siân Rizzo, Alex Tonks
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top